April 20, 2017

French regulator says up to 4,100 children victims of epilepsy drug

An estimated 2,150 to 4,100 children in France suffered a major malformation in the womb between 1967 and 2016 after their mothers took a treatment against epilepsy and bipolar disorders known as valproate, France's drug regulator said on Thursday.

Valproate, which has been manufactured in France by Sanofi under the brand Depakine in the field of epilepsy and Depakote and Depamide in bipolar disorders, is also believed to cause slow neurological development. Read more.


France sets up fund for Sanofi epilepsy drug victims - Reuters
'Duizenden Fransen hebben afwijking door anti-epilepticum' - NU

No comments:

Post a Comment